GlassScriptPhysician profile
Bruce J Kriegel
NPI 1376562447
$11,252.09
in general payments reported to CMS, 2019-2025
36 companies · $2,192 in 2025
The $2,192 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,001 · 2020: $533 · 2021: $400 · 2022: $1,737 · 2023: $2,404 · 2024: $1,986 · 2025: $2,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,517 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,516.99 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,976.86 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,435.88 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $797.04 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $769.95 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $642.91 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $607.36 | 2019-2025 | Farxiga, Brilinta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $573.35 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $518.41 | 2019-2025 | Watchman Flx |
| Alnylam Pharmaceuticals INC. | $471.49 | 2020-2025 | Onpattro, Amvuttra |
| Novo Nordisk INC | $449.13 | 2022-2025 | Ozempic, Wegovy |
| Scpharmaceuticals INC. | $406.63 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $368.63 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $313.52 | 2022-2025 | Verquvo, Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $213.64 | 2022-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $187.96 | 2024 | Arcalyst |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $174.22 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $161.97 | 2019-2022 | |
| Irhythm Technologies, INC. | $139.21 | 2023 | Zio Xt Patch |
| Daiichi Sankyo INC. | $131.72 | 2023-2024 | Injectafer |
| Esperion Therapeutics, INC. | $107.49 | 2022-2025 | Nexletol |
| Cvrx, INC. | $104.45 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $103.17 | 2022-2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $79.69 | 2023-2024 | Inpefa |
| Amarin Pharma, INC. | $71.40 | 2019-2020 | |
| Genzyme Corporation | $68.80 | 2019-2022 | |
| Medtronic, INC. | $64.63 | 2022-2025 | Azure Xt Dr Mri Surescan |
| Gilead Sciences, INC. | $43.83 | 2019 | |
| Abiomed | $42.15 | 2023 | Impella |
| Abbott Laboratories | $37.34 | 2019 | |
| Bardy Diagnostics, INC. | $35.00 | 2019-2020 | |
| Baxter Healthcare | $31.56 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Vivaquant INC, Dba Rhythm Express | $28.15 | 2025 | Rhythm Express |
| Medtronic Vascular, INC. | $26.80 | 2019 | |
| Philips North America LLC | $24.19 | 2023 | |
| Bridgebio Pharma, INC. | $22.39 | 2025 | Attruby |
| Impulse Dynamics (USA) INC. | $21.17 | 2024 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Kriegel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.